Chemoprevention of Anal Neoplasia Arising Secondary to Anogenital Human Papillomavirus Infection in Persons With HIV Infection. - Related Studies

Chemoprevention of Anal Neoplasia Arising Secondary to Anogenital Human Papillomavirus Infection in Persons With HIV Infection.

This study has been completed.

Study NCT00000764. Last updated on August 1, 2008. Information provided by National Institute of Allergy and Infectious Diseases (NIAID)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		HIV Infections
		Anus Neoplasms

2	Additional conditions recognized in this trial
		Acquired Immunodeficiency Syndrome
		Communicable Diseases
		Infection
		Neoplasms
		Papillomavirus Infections

3	More general conditions related to this trial
		Anus Diseases
		Colorectal Neoplasms
		Digestive System Diseases
		Digestive System Neoplasms
		DNA Virus Infections
		Gastrointestinal Diseases
		Gastrointestinal Neoplasms
		Immune System Diseases
		Immunologic Deficiency Syndromes
		Intestinal Diseases
		Intestinal Neoplasms
		Lentivirus Infections
		Neoplasms by Site
		Rectal Diseases
		Rectal Neoplasms
		Retroviridae Infections
		RNA Virus Infections
		Sexually Transmitted Diseases
		Sexually Transmitted Diseases, Viral
		Slow Virus Diseases
		Tumor Virus Infections
		Virus Diseases

4	Interventions listed in this trial
		Isotretinoin
		Interferon alfa-2a

5	Additional drug interventions recognized in this trial
		Interferon-alpha
		Interferons

6	More general drug interventions related to this trial
		Angiogenesis Inhibitors
		Angiogenesis Modulating Agents
		Anti-Infective Agents
		Antineoplastic Agents
		Antiviral Agents
		Dermatologic Agents
		Growth Inhibitors
		Growth Substances
		Immunologic Factors
		Pharmacologic Actions
		Physiological Effects of Drugs
		Therapeutic Uses

7	Sponsors listed in this trial
		National Institute of Allergy and Infectious Diseases (NIAID)
		Hoffmann-La Roche